230 related articles for article (PubMed ID: 14603611)
1. [Beta-1 blockade plus NO release. Additional organ protection for patients with hypertension].
MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603611
[No Abstract] [Full Text] [Related]
2. [Beta blocker improves the endothelial function. Gas-forming blood vessel protection].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974334
[No Abstract] [Full Text] [Related]
3. [Beta blockade plus NO release. Patients with heart failure can be loaded more].
MMW Fortschr Med; 2002 Oct; 144(41):57. PubMed ID: 12474368
[No Abstract] [Full Text] [Related]
4. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
Brodde OE; Philipp T
Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
[TBL] [Abstract][Full Text] [Related]
5. [Beta blocker activates release of NO. Radical against atherosclerosis].
MMW Fortschr Med; 2004 Mar; 146(11):57. PubMed ID: 15152777
[No Abstract] [Full Text] [Related]
6. Nebivolol: a new beta blocker on the horizon.
Katira R; Chauhan A
Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942
[No Abstract] [Full Text] [Related]
7. The role of nitric oxide in improving endothelial function and cardiovascular health: focus on nebivolol.
Bakris GL; Basile JN; Giles TD; Taylor AA
Am J Med; 2010 Jul; 123(7 Suppl 1):S2-8. PubMed ID: 20609695
[TBL] [Abstract][Full Text] [Related]
8. Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.
Sarafidis PA; Bakris GL
J Hypertens; 2007 Jan; 25(1):249-52; author reply 252-3. PubMed ID: 17143201
[No Abstract] [Full Text] [Related]
9. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI
Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
[TBL] [Abstract][Full Text] [Related]
10. Vasodilating versus first-generation β-blockers for cardiovascular protection.
Fares H; Lavie CJ; Ventura HO
Postgrad Med; 2012 Mar; 124(2):7-15. PubMed ID: 22437211
[TBL] [Abstract][Full Text] [Related]
11. Nebivolol: third-generation beta-blockade.
de Boer RA; Voors AA; van Veldhuisen DJ
Expert Opin Pharmacother; 2007 Jul; 8(10):1539-50. PubMed ID: 17661735
[TBL] [Abstract][Full Text] [Related]
12. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
Moen MD; Wagstaff AJ
Drugs; 2006; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
[TBL] [Abstract][Full Text] [Related]
13. [Initial data on nebivolol in heart failure. Beta blockers strengthen older hearts, too].
MMW Fortschr Med; 2003 May; 145(22):55. PubMed ID: 12866284
[No Abstract] [Full Text] [Related]
14. β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure.
Ambrosio G; Flather MD; Böhm M; Cohen-Solal A; Murrone A; Mascagni F; Spinucci G; Conti MG; van Veldhuisen DJ; Tavazzi L; Coats AJ
Heart; 2011 Feb; 97(3):209-14. PubMed ID: 21138861
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
16. [Nebivolol: a beta blocker with vasodilator properties].
Waeber B
Praxis (Bern 1994); 2000 Apr; 89(15):631-3. PubMed ID: 10804847
[TBL] [Abstract][Full Text] [Related]
17. The role of the new beta-blockers in treating cardiovascular disease.
Weber MA
Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide mechanisms of nebivolol.
Maffei A; Lembo G
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
[TBL] [Abstract][Full Text] [Related]
19. [Vasodilating beta blockers as effective antihypertensive agents. Results of a multicenter observational study].
von Fallois J; Faulhaber HD
MMW Fortschr Med; 2000 Jun; 142(24):45. PubMed ID: 10895582
[No Abstract] [Full Text] [Related]
20. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
Rozec B; Erfanian M; Laurent K; Trochu JN; Gauthier C
J Am Coll Cardiol; 2009 Apr; 53(17):1532-8. PubMed ID: 19389564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
